source
- AstraZeneca rekindles UK relationship, pledges £300M to expandAstraZeneca and the UK government are back in each other's good graces. AstraZeneca on Wednesday said it is lifting its UK investment pause, with a £300 million budget to finish construction of a n…Endpoints · 3mo ago↗ source
- STAT+: A patent win for Pfizer and BridgeBioA change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The ReadoutSTAT · 3mo ago↗ source
- Chiesi signs $1.9B deal to acquire KalVista and its approved drugChiesi is buying commercial biotech KalVista Pharmaceuticals for about $1.9 billion in an extension of the industry's vigorous spring shopping spree. The Italian pharma will pay $27 per share {$KAL…Endpoints · 3mo ago